Change search criteria ↓

Search results

9 projects found matching your search criteria:

  1. 1. Combined administration of muscarinic receptor antagonists and group II/III metabotropic glutamate (mGlu) receptor ligan…

    Principal investigator: prof. Andrzej Mikołaj Pilc

    Instytut Farmakologii PAN

    Call: OPUS 19, Panel: NZ7

  2. 2. The role of nitric oxide-dependent pathways in the procognitive effects of muscarinic and metabotropic glutamate recepto…

    Principal investigator: dr hab. Joanna Monika Wierońska

    Instytut Farmakologii PAN

    Call: OPUS 17, Panel: NZ7

  3. 3. The group III metabotropic glutamate receptors as a target for future antypsychotic drugs

    Principal investigator: prof. Andrzej Pilc

    Instytut Farmakologii PAN

    Call: MAESTRO 3, Panel: NZ7

  4. 4. Participation of transient receptor potential (TRP) channels premeable for calcium ions in memory formation and retrieva…

    Principal investigator: dr hab. Elżbieta Jolanta Salińska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 8, Panel: NZ4

  5. 5. Searching for molecular basis of addiction-prone phenotype - a role of astrocyte biomarkers (xc-, EAAT2) and metabotropi…

    Principal investigator: Ewa Magdalena Niedzielska-Andres

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: PRELUDIUM 6, Panel: NZ7

  6. 6. The role of selected metabotropic glutamate receptors in the mechanism of rapid antidepressant effect of RS-ketamine and…

    Principal investigator: dr hab. Agnieszka Pałucha-Poniewiera

    Instytut Farmakologii PAN

    Call: OPUS 14, Panel: NZ7

  7. 7. Investigation of the mechanisms of the neuroprotective effect of group II metabotropic receptors (mGluR2/3) agonist in a…

    Principal investigator: dr Ewelina Małgorzata Bratek

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 12, Panel: NZ7

  8. 8. The effect of the metabotropic glutamatergic receptor ligands on potentiating the antidepressant-like actvity of scopola…

    Principal investigator: Karolina Sylwia Podkowa

    Instytut Farmakologii PAN

    Call: PRELUDIUM 10, Panel: NZ7

  9. 9. Potential pharmacological strategies aimed at alleviating cognitive dysfunctions accompanying oncological therapy while …

    Principal investigator: dr hab. Joanna Monika Wierońska

    Instytut Farmakologii PAN

    Call: OPUS 26, Panel: NZ5

Graphic design and implementation: Jakub Piotrowski